SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010569
Filing Date
2020-08-13
Accepted
2020-08-13 17:16:05
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20200630x10q.htm 10-Q 921665
2 EX-31.1 cycc-20200630ex311570cc5.htm EX-31.1 14826
3 EX-31.2 cycc-20200630ex312e6d9e4.htm EX-31.2 15398
4 EX-32.1 cycc-20200630ex321577917.htm EX-32.1 5103
5 EX-32.2 cycc-20200630ex32214d427.htm EX-32.2 5447
  Complete submission text file 0001558370-20-010569.txt   3772912

Data Files

Seq Description Document Type Size
6 EX-101.INS cycc-20200630.xml EX-101.INS 649287
7 EX-101.SCH cycc-20200630.xsd EX-101.SCH 31692
8 EX-101.CAL cycc-20200630_cal.xml EX-101.CAL 36563
9 EX-101.DEF cycc-20200630_def.xml EX-101.DEF 124502
10 EX-101.LAB cycc-20200630_lab.xml EX-101.LAB 279535
11 EX-101.PRE cycc-20200630_pre.xml EX-101.PRE 235586
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 201100251
SIC: 2834 Pharmaceutical Preparations